CellWell record HH-160474
Investigating the clinical efficacy, safety and molecular mechanism of sulforaphane in autism spectrum disorder: an integrated study combining meta-analysis, network pharmacology, and computational biology
Junzi Long; Xingxing Liao; Zhiqing Tang; Kaiyue Han; Jiarou Chen; Xianna Wang; Jianjun Liu; Yan Zhang; Hao Zhang
2025
In plain language
Sulforaphane supplementation for 4-10 weeks reduced social responsiveness scale scores in autism spectrum disorder compared to placebo without significant adverse effects.
- Evidence
- Established
- Design
- Meta-analysis
Cite this record: https://thecellwell.org/studies/HH-160474
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.